Werewolf Therapeutics (HOWL) Other Working Capital Changes (2020 - 2026)
Werewolf Therapeutics (HOWL) posted quarterly Other Working Capital Changes of -$2.8 million for Q2 2026, down 613.66% year-over-year from $539072.8 in Q2 2025, and down 350.24% on a QoQ basis from -$615000.0 in Q1 2026.
Werewolf Therapeutics (HOWL) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Werewolf Therapeutics has reported Other Working Capital Changes for 7 years, with the latest figure at -$2.8 million in Q2 2026.
- Other Working Capital Changes for Q2 2026 came in at -$2.8 million, down 613.66% year-over-year; the trailing twelve-month figure through Jun 2026 was -$4.0 million (down 227.32% YoY), and the FY2025 annual result was -$1.6 million, up 3.17% from the prior year.
- Other Working Capital Changes retreated to -$2.8 million in Q2 2026, from -$615000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $4.5 million in Q2 2022 and troughed at -$3.1 million in Q4 2022.
- A 5-year average of -$175555.6 and a median of -$310000.0 in 2024 frame the typical range for Other Working Capital Changes.
- The widest annual swing landed in 2022, when Other Working Capital Changes jumped 8120.75%; it then slumped 861.54% in 2024.
- A 5-year view of Other Working Capital Changes shows it stood at -$3.1 million in 2022, then surged by 66.19% to -$1.1 million in 2023, then soared by 84.09% to -$169000.0 in 2024, then retreated by 23.67% to -$209000.0 in 2025, then slumped by 1224.88% to -$2.8 million in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were -$2.8 million in Q2 2026, -$615000.0 in Q1 2026, and -$209000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Werewolf Therapeutics | 20.90 Mn | 20.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.77 Mn |
| Jun 30, 2026 | -2.77 Mn |
| Jun 30, 2026 | -2.77 Mn |
| Mar 31, 2026 | -615,000.00 |
| Mar 31, 2026 | -615,000.00 |
| Mar 31, 2026 | -615,000.00 |
| Jun 30, 2025 | 563,000.00 |
| Jun 30, 2025 | 563,000.00 |
| Jun 30, 2025 | 563,000.00 |
| Mar 31, 2025 | -563,000.00 |
| Mar 31, 2025 | -563,000.00 |
| Mar 31, 2025 | -563,000.00 |
| Jun 30, 2024 | -933,000.00 |
| Jun 30, 2024 | -933,000.00 |
| Jun 30, 2024 | -933,000.00 |
| Mar 31, 2024 | -407,000.00 |
| Mar 31, 2024 | -407,000.00 |
| Mar 31, 2024 | -407,000.00 |
| Dec 31, 2023 | 3.17 Mn |
| Dec 31, 2023 | 3.17 Mn |